Halozyme Therapeutics, Inc. - Bathi mangsa ngarep HALO

HALO (Halozyme Therapeutics, Inc.) - tandha merek perusahaan

Halozyme Therapeutics (HALO) outsources component manufacturing to third-party contractors, focusing instead on licensing its proprietary developments to corporate behemoths. This price chart illustrating valuation trends confirms the effectiveness of the ENHANZE platform, which consistently generates high royalties and profits at the level of 1.18. Management has established a profitable monetization scheme, allocating significant funds toward share buybacks for beneficiaries.

HALO: Bathi mangsa ngarep halozyme.com 04.07.2022 - 18.11.2026

Halozyme Inc. - rincian analitis lan metrik utama (HALO)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:Halozyme, HALO
Barang utama Halozyme Therapeutics, Inc.

To identify fundamental support for Halozyme Therapeutics (HALO), it is essential to evaluate the synergy between automated enzyme synthesis and expert clinical trial oversight. The expected profit dynamics on GURU.Markets visualize the trajectory of future net returns, aggregating session closing points to determine long-term business efficiency. While the positive trend confirms management quality, purchasing at the upper boundary of the indicator increases the risk of a drawdown should market sentiment shift.

Analisis pesaing Halozyme Therapeutics

Bathi mangsa ngarep ONC|RVMD: Penghasilan resik sing dikarepake|Bathi mangsa ngarep AAPG (Ascentage)|CGON (CG Oncology Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep URGN (urogen.com)|BCAX - Bathi mangsa ngarep|PSNL: Bathi mangsa ngarep|ERAS - Proyeksi bathi mangsa ngarep|Delcath (DCTH) - Bathi sing dikarepake|YmAbs - Penghasilan resik sing dikarepake|AURA (Aura Biosciences Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Candel Therapeutics CADL|Proyeksi bathi mangsa ngarep ARAY|SLS - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ACTU (Actuate Therapeutics Inc)|Prakiraan bathi perusahaan Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Protara Therapeutics, Inc.|FATE: Proyeksi bathi mangsa ngarep|WHWK - Prakiraan bathi perusahaan|Bathi sing dikarepake TScan Therapeutics, Inc.|Champions Oncology - Bathi forward|Proyeksi bathi mangsa ngarep XBIT|Prakiraan bathi perusahaan CEL-SCI Corp|Bathi sing dikarepake OS Therapies OSTX|Penghasilan resik sing dikarepake RADX|artivabio.com - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Bathi mangsa ngarep|TPST: Bathi resik mangsa ngarep|XLO (Xilio) - Proyeksi bathi mangsa ngarep|renovarobio.com (RENB) - Prakiraan bathi perusahaan|Bathi sing dikarepake Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep OKUR (OnKure Therapeutics, Inc.)|Penghasilan resik sing dikarepake GDTC|Curis Inc. - Proyeksi bathi mangsa ngarep|APLM (apollomicsinc.com) - Prakiraan bathi resik|THAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Advanced Biomed Inc. (ADVB)|Bathi sing dikarepake Genprex, Inc|Proyeksi bathi mangsa ngarep calidibio.com|Bathi sing dikarepake Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep SLRX (salariuspharma.com)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake